TransMedics Group, Inc. (TMDX)
71.86
-4.66
(-6.09%)
USD |
NASDAQ |
Oct 16, 13:42
TransMedics Group SG&A Expense (TTM) : 218.27M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 218.27M |
| March 31, 2026 | 204.53M |
| December 31, 2025 | 185.17M |
| September 30, 2025 | 180.63M |
| June 30, 2025 | 177.27M |
| March 31, 2025 | 176.08M |
| December 31, 2024 | 168.62M |
| September 30, 2024 | 156.27M |
| June 30, 2024 | 144.27M |
| March 31, 2024 | 130.73M |
| December 31, 2023 | 119.55M |
| September 30, 2023 | 106.72M |
| June 30, 2023 | 92.92M |
| March 31, 2023 | 80.94M |
| December 31, 2022 | 69.90M |
| September 30, 2022 | 60.17M |
| June 30, 2022 | 53.66M |
| March 31, 2022 | 45.44M |
| December 31, 2021 | 38.28M |
| Date | Value |
|---|---|
| September 30, 2021 | 32.46M |
| June 30, 2021 | 27.62M |
| March 31, 2021 | 24.32M |
| December 31, 2020 | 24.19M |
| September 30, 2020 | 24.18M |
| June 30, 2020 | 25.21M |
| March 31, 2020 | 25.60M |
| December 31, 2019 | 23.60M |
| September 30, 2019 | 21.80M |
| June 30, 2019 | 18.08M |
| March 31, 2019 | 14.72M |
| December 31, 2018 | 12.32M |
| September 30, 2018 | 9.575M |
| June 30, 2018 | 8.589M |
| March 31, 2018 | 8.02M |
| December 31, 2017 | 7.606M |
| September 30, 2017 | 5.972M |
| June 30, 2017 | 4.159M |
| March 31, 2017 | 1.829M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Boston Scientific Corp. | 7.159B |
| Abbott Laboratories | 13.94B |
| Alphatec Holdings, Inc. | 524.06M |
| Baxter International, Inc. | 2.932B |
| Becton, Dickinson & Co. | 5.233B |